Up a level |
Reeves, Barnaby C, Scott, Lauren J, Taylor, Jodi, Hogg, Ruth, Rogers, Chris A, Wordsworth, Sarah, Townsend, Daisy, Muldrew, Alyson, Peto, Tunde, Violato, Mara et al (show 6 more authors)
(2016)
The Effectiveness, cost-effectiveness and acceptability of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual randomised balanced incomplete block triald.
HEALTH TECHNOLOGY ASSESSMENT, 20 (80).
1-+.
Bailey, Clare, Scott, Lauren J, Rogers, Chris A, Reeves, Barnaby C, Hamill, Barbra, Peto, Tunde, Chakravarthy, Usha, Harding, Simon P ORCID: 0000-0003-4676-1158 and IVAN Study Group,
(2019)
Intralesional Macular Atrophy in Anti–Vascular Endothelial Growth Factor Therapy for Age-Related Macular Degeneration in the IVAN Trial.
OPHTHALMOLOGY, 126 (1).
pp. 75-86.
Bailey, Clare, Scott, Lauren J, Rogers, Chris A, Reeves, Barnaby C, Hamill, Barbra, Peto, Tunde, Chakravarthy, Usha and Harding, Simon P ORCID: 0000-0003-4676-1158
(2019)
Re: Bailey et al: Intralesional macular atrophy in anti-vascular endothelial growth factor therapy for age-related macular degeneration in the IVAN trial (Ophthalmology. 2019;126:75-86) REPLY.
OPHTHALMOLOGY, 126 (9).
E72-E73.
Chakravarthy, Usha, Harding, Simon P ORCID: 0000-0003-4676-1158, Rogers, Chris A, Downes, Susan, Lotery, Andrew J, Dakin, Helen A, Culliford, Lucy, Scott, Lauren J, Nash, Rachel L, Taylor, Jodi et al (show 6 more authors)
(2015)
A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN).
HEALTH TECHNOLOGY ASSESSMENT, 19 (78).
pp. 1-297.